Fredrika Svahn
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Genetic variants and down-regulation of CACNA1H in pheochromocytoma.
Journal: Endocrine-related cancer
Published: March 07, 2023
TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?
TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?
Journal: Endocrine pathology
Published: December 29, 2022
TERT promoter mutations in primary and secondary WHO grade III meningioma.
Journal: Brain pathology (Zurich, Switzerland)
Published: May 24, 2020
Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior.
Journal: The American journal of surgical pathology
Published: November 20, 2018
TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
Journal: International journal of molecular medicine
Published: January 10, 2018
Telomerase reverse transcriptase promoter hypermethylation is associated with metastatic disease in abdominal paraganglioma.
Journal: Clinical endocrinology
Published: November 14, 2017
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
Journal: JAMA oncology
Published: April 07, 2017
Absence of the BRAF V600E mutation in pheochromocytoma.
Journal: Journal of endocrinological investigation
Published: August 27, 2015
Absence of KMT2D/MLL2 mutations in abdominal paraganglioma.
Journal: Clinical endocrinology
Published: August 26, 2015
Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.
Journal: Genes, chromosomes & cancer
Published: March 18, 2015
Immunohistochemical NF1 analysis does not predict NF1 gene mutation status in pheochromocytoma.
Journal: Endocrine pathology
Published: November 19, 2014
The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas.
Journal: Epigenetics
Published: October 24, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026